Last reviewed · How we verify
Sevoflurane or Propofol — Competitive Intelligence Brief
marketed
General anesthetic
GABA-A receptor, NMDA glutamate receptor
Anesthesiology
Small molecule
Live · refreshed every 30 min
Target snapshot
Sevoflurane or Propofol (Sevoflurane or Propofol) — University Health Network, Toronto. Sevoflurane and Propofol are general anesthetics that enhance inhibitory GABAergic neurotransmission and suppress excitatory glutamatergic signaling in the central nervous system to produce unconsciousness.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Sevoflurane or Propofol TARGET | Sevoflurane or Propofol | University Health Network, Toronto | marketed | General anesthetic | GABA-A receptor, NMDA glutamate receptor | |
| Sevoflurane inhalant product | Sevoflurane inhalant product | Sunnybrook Health Sciences Centre | marketed | Volatile inhalational anesthetic | GABA-A receptor, NMDA glutamate receptor | |
| Sevorane (sevoflurane, Abbott) | Sevorane (sevoflurane, Abbott) | Medical University of Gdansk | marketed | Volatile anesthetic | GABA-A receptor, NMDA glutamate receptor | |
| General sevoflurane anaesthesia | General sevoflurane anaesthesia | KK Women's and Children's Hospital | phase 3 | Volatile anesthetic agent | GABA-A receptor, NMDA glutamate receptor | |
| Inhaled sedation with sevoflurane | Inhaled sedation with sevoflurane | University Hospital, Clermont-Ferrand | phase 3 | Volatile anesthetic | GABA-A receptor, NMDA glutamate receptor | |
| SEVOFLURANE | SEVOFLURANE | marketed | General Anesthetic [EPC] | 1995-01-01 | ||
| Suprane | DESFLURANE | Baxter | marketed | General Anesthetic [EPC] | GABA-A receptor; anion channel | 1992-01-01 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (General anesthetic class)
- Assistance Publique - Hôpitaux de Paris · 1 drug in this class
- Chung-Ang University Gwangmyeong Hospital · 1 drug in this class
- Fresenius Kabi · 1 drug in this class
- Gangnam Severance Hospital · 1 drug in this class
- Rigshospitalet, Denmark · 1 drug in this class
- Seoul National University Hospital · 1 drug in this class
- Universidade Estadual Paulista Júlio de Mesquita Filho · 1 drug in this class
- University Health Network, Toronto · 1 drug in this class
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Sevoflurane or Propofol CI watch — RSS
- Sevoflurane or Propofol CI watch — Atom
- Sevoflurane or Propofol CI watch — JSON
- Sevoflurane or Propofol alone — RSS
- Whole General anesthetic class — RSS
Cite this brief
Drug Landscape (2026). Sevoflurane or Propofol — Competitive Intelligence Brief. https://druglandscape.com/ci/sevoflurane-or-propofol. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab